Back to Henry Kravis
Henry Kravis → BBIO via Kohlberg Kravis Roberts & Co. L.P.
Henry Kravis BBIO Position History
BridgeBio Pharma, Inc. • Healthcare
Quarters held
16
Latest value
$649K
Q2 2026
Peak value
$1.3B
First seen
Q1 2023
Quarter-by-quarter history
Every disclosed snapshot
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q2 2026 | $649K | 385.0K | — | — |
| Q2 2026 | $987.7M | 13.26M | — | — |
| Q1 2026 | $984.8M | 13.26M | — | — |
| Q4 2025 | $1B | 13.26M | — | — |
| Q3 2025 | $688.8M | 13.26M | — | — |
| Q2 2025 | $572.6M | 13.26M | — | — |
| Q1 2025 | $665.9M | 19.26M | — | — |
| Q4 2024 | $693.2M | 25.26M | — | — |
| Q3 2024 | $643.1M | 25.26M | — | — |
| Q2 2024 | $786.8M | 31.06M | — | — |
| Q1 2024 | $960.4M | 31.06M | — | — |
| Q4 2023 | $1.3B | 31.06M | — | — |
| Q3 2023 | $819.1M | 31.06M | — | — |
| Q3 2023 | $819.1M | 31.06M | — | — |
| Q2 2023 | $534.2M | 31.06M | — | — |
| Q1 2023 | $515M | 31.06M | — | — |